SARS-CoV-2 ?associated SARI. SARS-CoV-2
Conditions
Sponsors
Kashan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: possibility of involving to Covid-19 PaO2/FiO2 50% consciousness of patient and to be able to complete letter of satisfaction minimum 18 years old
Exclusion criteria
Exclusion criteria: Pregnancy Immunodeficiency such as patient with Severe combined immune deficiency and HIV Allergy to mouth rinse ImmunoSuppressant drug consumer such as transplantation recipient patient Dissatisfaction with participating in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Duration of hospitalization. Timepoint: End of study. Method of measurement: Calculation.;Mortality status. Timepoint: 28 days after admit day. Method of measurement: percent (live/ dead).;Xerostomia. Timepoint: Daily during first day of hospitalization until 28 days. Method of measurement: percent (has/has not).;Change of Taste sens. Timepoint: Daily during first day of hospitalization until 28 days. Method of measurement: percent (has/has not).;New oral erythematous lesion. Timepoint: Daily during first day of hospitalization until 28 days. Method of measurement: percent (has/has not).;New oral ulcer. Timepoint: Daily during first day of hospitalization until 28 days. Method of measurement: percent (has/has not ). | — |
Secondary
| Measure | Time frame |
|---|---|
| Para clinical outcome(White blood cell count). Timepoint: The first day and the last day of discharge. Method of measurement: cell number x 1000.;Para clinical outcome (blood potassium). Timepoint: The first day and the last day of discharge. Method of measurement: milligrams per decilitre.;Para clinical outcome (blood magnesium). Timepoint: The first day and the last day of discharge. Method of measurement: milligrams per decilitre.;Para clinical outcome (platelet count). Timepoint: The first day and the last day of discharge. Method of measurement: cell number x 1000.;Para clinical outcome (C Reactive protein). Timepoint: The first day and the last day of discharge. Method of measurement: milligrams per decilitre.;Para clinical outcome(CURB65)). Timepoint: The first day and the last day of discharge. Method of measurement: scale.;Para clinical outcome (Creatinine). Timepoint: The first day and the last day of discharge. Method of measurement: milligrams per decilitre.;Para clinical outcome(Respiratory rate per minute). Timepoint: The first day and the last day of discharge. Method of measurement: number of breath per minute.;Para clinical outcome(blood pressure). Timepoint: The first day and the last day of discharge. Method of measurement: millimetre of mercury.;Para clinical outcome(Body temperature). Timepoint: The first day and the last day of discharge. Method of measurement: centigrade.;Para clinical outcome (heart rate per minute). Timepoint: The first day and the last day of discharge. Method of measurement: beats per minute.;Para clinical outcome (Blood Urea nitrogen). Timepoint: The first day and the last day of discharge. Method of measurement: milligrams per decilitre.;Para clinical outcome (blood nutriome). Timepoint: The first day and the last day of discharge. Method of measurement: milligrams per decilitre.;Para clinical outcome (Blood glucose). Timepoint: The first day and the last day of discharge. Method of measurement: milligrams per decilitre. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactElaheh GhasemzadehHosseini
Kashan University of Medical Sciences
Outcome results
None listed